115 related articles for article (PubMed ID: 34126859)
21. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Sreeharsha N; Morsy MA; Gupta S; Attimarad M; Shinu P; Venugopala KN
PLoS One; 2021; 16(3):e0248857. PubMed ID: 33739996
[TBL] [Abstract][Full Text] [Related]
22. Ophthalmic Delivery of Riboflavin Loaded Nanoparticulate Suspension in Keratoconus: A Preclinical Study in Rabbit Model.
Zhang L; Fang C; Wu Q
J Biomed Nanotechnol; 2021 Sep; 17(9):1866-1873. PubMed ID: 34688332
[TBL] [Abstract][Full Text] [Related]
23. Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel.
Pandurangan DK; Bodagala P; Palanirajan VK; Govindaraj S
Int J Pharm Investig; 2016; 6(1):56-62. PubMed ID: 27014620
[TBL] [Abstract][Full Text] [Related]
24. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.
Ameeduzzafar ; Imam SS; Abbas Bukhari SN; Ahmad J; Ali A
Int J Biol Macromol; 2018 Mar; 108():650-659. PubMed ID: 29199125
[TBL] [Abstract][Full Text] [Related]
25. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
[TBL] [Abstract][Full Text] [Related]
26. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole.
Kakkar S; Karuppayil SM; Raut JS; Giansanti F; Papucci L; Schiavone N; Kaur IP
Int J Pharm; 2015 Nov; 495(1):276-289. PubMed ID: 26325312
[TBL] [Abstract][Full Text] [Related]
27. [Ion-sensitive nanoemulsion-in situ gel system for ophthalmic delivery of flurbiprofen axetil].
Shen JQ; Gan Y; Gan L; Zhu CL; Zhu JB
Yao Xue Xue Bao; 2010 Jan; 45(1):120-5. PubMed ID: 21351461
[TBL] [Abstract][Full Text] [Related]
28. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits.
Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH
Int J Pharm; 2013 Feb; 443(1-2):293-305. PubMed ID: 23333217
[TBL] [Abstract][Full Text] [Related]
29. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation.
Lihong W; Xin C; Yongxue G; Yiying B; Gang C
Drug Dev Ind Pharm; 2014 Oct; 40(10):1402-10. PubMed ID: 23944837
[TBL] [Abstract][Full Text] [Related]
30. A novel thermo-sensitive hydrogel-based on poly(N-isopropylacrylamide)/hyaluronic acid of ketoconazole for ophthalmic delivery.
Zhu M; Wang J; Li N
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1282-1287. PubMed ID: 28826241
[TBL] [Abstract][Full Text] [Related]
31. Chitosan based mucoadhesive nanoparticles of ketoconazole for bioavailability enhancement: formulation, optimization, in vitro and ex vivo evaluation.
Modi J; Joshi G; Sawant K
Drug Dev Ind Pharm; 2013 Apr; 39(4):540-7. PubMed ID: 22436084
[TBL] [Abstract][Full Text] [Related]
32. [A preliminary study on the safety of berberine solution in rabbit eyes with topical application].
Zhang Y; Bai F; Tao H
Zhonghua Yan Ke Za Zhi; 2020 Feb; 56(2):131-137. PubMed ID: 32074824
[No Abstract] [Full Text] [Related]
33. The hen's egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: Quantification using Photoshop® and ImageJ.
McKenzie B; Kay G; Matthews KH; Knott RM; Cairns D
Int J Pharm; 2015 Jul; 490(1-2):1-8. PubMed ID: 25980731
[TBL] [Abstract][Full Text] [Related]
34. Spanlastics--a novel nanovesicular carrier system for ocular delivery.
Kakkar S; Kaur IP
Int J Pharm; 2011 Jul; 413(1-2):202-10. PubMed ID: 21540093
[TBL] [Abstract][Full Text] [Related]
35. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
[TBL] [Abstract][Full Text] [Related]
36. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles.
Lou J; Hu W; Tian R; Zhang H; Jia Y; Zhang J; Zhang L
Int J Nanomedicine; 2014; 9():2517-25. PubMed ID: 24904211
[TBL] [Abstract][Full Text] [Related]
37. Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery.
Ambhore NP; Dandagi PM; Gadad AP
Drug Deliv Transl Res; 2016 Feb; 6(1):48-56. PubMed ID: 26545605
[TBL] [Abstract][Full Text] [Related]
38. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
39. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
[TBL] [Abstract][Full Text] [Related]
40. Photochemical toxicity of drugs intended for ocular use.
Sahu RK; Singh B; Saraf SA; Kaithwas G; Kishor K
Arh Hig Rada Toksikol; 2014 Jun; 65(2):157-67. PubMed ID: 24846953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
